[5-HT3 receptor antagonists as a new therapeutic principle in rheumatology?].
Klinikum Innenstadt, Universität München, Friedrich-Baur-Institut, Ziemssenstr. 1 80336 München.
D
D
Pongratz
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005356:Fibromyalgia / Q000188:drug therapy*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D011985:Receptors, Serotonin / Q000187:drug effects*; D044406:Receptors, Serotonin, 5-HT3; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D000077526:Tropisetron
D007211:Indoles; D011985:Receptors, Serotonin; D044406:Receptors, Serotonin, 5-HT3; D012702:Serotonin Antagonists; D000077526:Tropisetron